Current opinion of presentation of dysphagia and dysphonia in patients with coronavirus disease 2019 DOI
Anna Miles, Martin B. Brodsky

Current Opinion in Otolaryngology & Head & Neck Surgery, Journal Year: 2022, Volume and Issue: unknown

Published: Aug. 4, 2022

Purpose of review Dysphagia and dysphonia are common presentations both acute long coronavirus disease 2019 (COVID-19). The majority peer-reviewed publications in 2020 early 2021 were expert guidance consensus statements to support dysphagia management multidisciplinary teams while protecting clinicians patients from the severe respiratory syndrome 2 (SARS-CoV-2) virus. This discusses primary data published 2021–2022, focusing on patient presentations, pathophysiology, evidence for interventions. Recent findings Clinicians researchers amassed knowledge cross-system presentation with COVID-19, requiring ICU stays those mild-to-moderate presenting outpatient clinics. Pre-COVID-19 health status, hospitalization experience, presence neurological symptoms, impact virus upper aerodigestive system need consideration management. Long-term manifested COVID-19 require otolaryngologist speech-language pathologist input. Summary Changes immunity through population vaccination variations SARS-CoV-2 mutations means prevalence challenging interpret. However, there is no doubt long-term our complex a team tailored approach each required.

Language: Английский

Inflammatory Profiles of Tracheal Biopsies From SARS-CoV-2 Patients DOI Creative Commons
Giacomo Fiacchini, Agnese Proietti, Anello Marcello Poma

et al.

Frontiers in Microbiology, Journal Year: 2022, Volume and Issue: 13

Published: March 16, 2022

An increasing number of laryngotracheal complications in mechanically ventilated COVID-19 patients has been reported the last few months. Many etiopathogenetic hypotheses were proposed but no clear explanation these was identified. In this paper we evaluated possibility that tracheal mucosa could be a high viral replication site weaken epithelium itself.Subjects for group and control selected retrospectively according to specific criteria. Patients' basic clinical data recorded analyzed. Tracheal samples both groups collected during surgical tracheostomies then analyzed from histological genetic-transcriptional point view.Four enrolled study compared with four non-COVID-19 patients. No identified groups. The SARS-CoV-2 detected one out samples. A subepithelial inflammatory lymphomonocyte infiltrate observed all two cases showed vasculitis small vessels associated foci coagulative necrosis. Two gene sets (HALLMARK_INFLAMMATORY_RESPONSE HALLMARK_ESTROGEN_RESPONSE_LATE) significantly deregulated group.The altered response another possible complications.

Language: Английский

Citations

6

DYSPHAGIA OCCURRENCE IN COVID-19-POSITIVE PATIENTS IN TWO HOSPITALS IN BRAZIL DOI Creative Commons
José Ribamar do NASCIMENTO, Camila Ferreira CERON, Alana Verza Signorini

et al.

Arquivos de Gastroenterologia, Journal Year: 2022, Volume and Issue: 59(3), P. 439 - 446

Published: Sept. 1, 2022

ABSTRACT Background COVID-19 comprises a respiratory infection resulting from contamination by SARS-CoV-2, with acute failure being one of its main characteristics, leading to high frequency orotracheal intubation (OTI), which in turn increases the risk for dysphagia. Since this can lead pulmonary impairment, knowing real occurrence dysphagia part Brazilian population and associations allows early effective clinical management multidisciplinary team relation patients. Objective To verify COVID-19-positive adult patients two reference hospitals care pandemic. Methods This was prospective, longitudinal observational study carried out private Brazil, both references coronavirus isolation. Data were initially collected consulting medical records each patient. Information regarding sex, age, previous diseases, testing, OTI period. After data collection, speech-language assessment swallowing patient using adapted Gugging Swallowing Screen (GUSS), ASHA NOMS Functional Oral Intake Scale (FOIS). Results A total 129 participants evaluated, mean age 72 years. According GUSS scale, 9.3% presented normal/functional swallowing, while 90.7% dysphagia, mild 17.05%, moderate 33.33%, severe 37.98%. As results NOMS, majority (36.5%) at level 1, represents who is not able receive his or her food supply orally, having need use tube feedings. line observed FOIS whereby most (42.1%) classified as Level I, when intake occurs exclusively through feeding tubes, no oral supply. Of participants, 59% them required OTI. When comparing time severity there statistically significant difference, more longer remained intubated. Conclusion: There incidence oropharyngeal COVID-19, increased during periods

Language: Английский

Citations

6

Laryngeal complications after endotracheal intubation and prone positioning in patients with coronavirus disease 2019 DOI Creative Commons

Shiori Aibara,

Masahiro Okada,

Kaori Tanaka‐Nishikubo

et al.

Laryngoscope Investigative Otolaryngology, Journal Year: 2022, Volume and Issue: 7(6), P. 1909 - 1914

Published: Oct. 21, 2022

Laryngeal complications have been reported after endotracheal intubation and prone positioning in patients with critical coronavirus disease 2019 (COVID-19), but their association is unclear. In this study, we investigated the rate of laryngeal COVID-19 compared to an alternative condition (control group).

Language: Английский

Citations

6

Prevalence and recovery of dysphonia in COVID-19 patients requiring intensive care treatment DOI Creative Commons
Nicola Clayton, Amy Freeman‐Sanderson,

Elizabeth Walker

et al.

Australian Critical Care, Journal Year: 2023, Volume and Issue: 37(1), P. 151 - 157

Published: Sept. 13, 2023

Language: Английский

Citations

3

Current opinion of presentation of dysphagia and dysphonia in patients with coronavirus disease 2019 DOI
Anna Miles, Martin B. Brodsky

Current Opinion in Otolaryngology & Head & Neck Surgery, Journal Year: 2022, Volume and Issue: unknown

Published: Aug. 4, 2022

Purpose of review Dysphagia and dysphonia are common presentations both acute long coronavirus disease 2019 (COVID-19). The majority peer-reviewed publications in 2020 early 2021 were expert guidance consensus statements to support dysphagia management multidisciplinary teams while protecting clinicians patients from the severe respiratory syndrome 2 (SARS-CoV-2) virus. This discusses primary data published 2021–2022, focusing on patient presentations, pathophysiology, evidence for interventions. Recent findings Clinicians researchers amassed knowledge cross-system presentation with COVID-19, requiring ICU stays those mild-to-moderate presenting outpatient clinics. Pre-COVID-19 health status, hospitalization experience, presence neurological symptoms, impact virus upper aerodigestive system need consideration management. Long-term manifested COVID-19 require otolaryngologist speech-language pathologist input. Summary Changes immunity through population vaccination variations SARS-CoV-2 mutations means prevalence challenging interpret. However, there is no doubt long-term our complex a team tailored approach each required.

Language: Английский

Citations

5